Abstract PS5-01-23: Validation of the HER2DX Genomic Test in First-Line Advanced HER2-Positive Breast Cancer: Identifying Long-Term Responders to THPMarcin Kubeczko, F. Braso-Maritany, Rodrigo Sánchez-Bayona et al.|Clinical Cancer Research|2026Cited by 0